Neuroone Medical Technologies (NMTC) Finished Goods (2022 - 2026)

Neuroone Medical Technologies has disclosed Finished Goods across 5 years of filings, most recently posting $721343.0 for Q1 2026.

• Quarterly Finished Goods rose 32.19% year-over-year to $721343.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $721343.0 (up 32.19% YoY) and the FY2025 annual result came in at $1.2 million, down 21.75% from the prior year.
• Finished Goods grew to $721343.0 in Q1 2026, from $518209.0 in the prior quarter.
• Across five years, Finished Goods topped out at $1.6 million in Q3 2024 and bottomed at $73968.0 in Q3 2022.
• The 5-year median for Finished Goods is $703302.0 (2024), against an average of $669977.5.
• Year-over-year, Finished Goods soared 768.35% in 2024 and slumped 41.11% in 2025.
• Neuroone Medical Technologies' Finished Goods stood at $73968.0 in 2022, then surged by 143.47% to $180092.0 in 2023, then soared by 388.62% to $879966.0 in 2024, then slumped by 41.11% to $518209.0 in 2025, then soared by 39.2% to $721343.0 in 2026.
• According to Business Quant data, Finished Goods over the past three periods registered $721343.0, $518209.0, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.